CYBIN INC.

Profile

Company Names

CYBIN INC.

Addresses

100 KING ST. WEST, SUITE 5600, TORONTO, A6 M5X 1C9

100 KING STREET WEST, SUITE 5600, TORONTO, A6 M5X1C9

Phone Numbers

(866) 292-4601
(908) 764-8385

 

Entity Type:

CORPORATION

Industry:

OTHER

Year Incorporated:

2016

State Incorporated:

ONTARIO, CANADA

Total Amount Raised:

$162,269,582.00

Number of Funding Rounds:

17
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
17
2026-03-10 
$0.00 
INDEFINITE 
INDEFINITE 
 
16
2025-12-31 
$0.00 
$114,154.00 
$114,154.00 
 
15
2025-11-14 
$0.00 
$288,580.00 
$288,580.00 
 
14
2025-10-01 
$0.00 
$601,865.00 
$601,865.00 
 
13
2025-08-29 
$0.00 
$120,070.00 
$120,070.00 
 
12
2025-08-15 
$0.00 
$637,404.00 
$637,404.00 
 
11
2025-06-30 
$50,000,000.00 
$50,000,000.00 
$0.00 
Debt 
10
2024-08-15 
$0.00 
$3,249,666.00 
$3,249,666.00 
 
9
2024-04-05 
$0.00 
$1,904,692.00 
$1,904,692.00 
 
8
2024-03-19 
$108,699,999.00 
$108,699,999.00 
$0.00 
Equity 
7
2023-11-16 
$0.00 
$1,690,000.00 
$1,690,000.00 
 
6
2023-06-29 
$0.00 
$1,991,037.00 
$1,991,037.00 
 
5
2022-03-08 
$317,098.00 
$317,098.00 
$0.00 
 
4
2022-03-04 
$17,725.00 
$17,725.00 
$0.00 
 
3
2020-12-14 
$342,513.00 
$342,513.00 
$0.00 
 
2
2020-11-27 
$2,892,247.00 
$2,892,247.00 
$0.00 
 
1
2020-11-05 
$0.00 
$35,308.00 
$35,308.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
AARON 
 
BARTLONE 
EXECUTIVE OFFICER
GREG 
 
CAVERS 
EXECUTIVE OFFICER
LORI 
 
CHALLENGER 
EXECUTIVE OFFICER
MICHAEL 
 
COLA 
EXECUTIVE OFFICER
DOUG 
 
DRYSDALE 
EXECUTIVE OFFICER, DIRECTOR
DOUGLAS 
 
DRYSDALE 
EXECUTIVE OFFICER
GABE 
 
FAHEL 
EXECUTIVE OFFICER
GABRIEL 
 
FAHEL 
EXECUTIVE OFFICER
THERESA 
 
FIRESTONE 
DIRECTOR
GRANT 
 
FROESE 
DIRECTOR
PAUL 
 
GLAVINE 
DIRECTOR, EXECUTIVE OFFICER
BRETT 
 
GREEN 
EXECUTIVE OFFICER
BRETT 
 
GREENE 
EXECUTIVE OFFICER
ERIC 
 
HOSKINS 
DIRECTOR
JOHN 
 
KANAKIS 
EXECUTIVE OFFICER, DIRECTOR
JUKKA 
 
KARJALAINEN 
EXECUTIVE OFFICER
MARK 
 
LAWSON 
DIRECTOR
ALEX 
 
NIVOROZHKIN 
EXECUTIVE OFFICER
MICHAEL 
 
PALFREYMAN 
EXECUTIVE OFFICER
JACQUELINE 
 
PORIADJIAN 
EXECUTIVE OFFICER
GEORGE 
 
TZIRAS 
DIRECTOR, EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2026-03-10 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2025-12-31 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2025-11-14 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2025-10-01 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2025-08-29 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2025-08-15 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2025-08-15 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2025-06-30 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2024-08-15 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2024-04-05 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-03-19 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2023-11-16 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2023-06-29 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-11-27 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-12-14 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2022-03-08 
D
OTHER 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2022-03-04 
D
OTHER 
 
DECLINE TO DISCLOSE 
 
2020-11-05 
D
OTHER 
 
DECLINE TO DISCLOSE 
 
2020-11-05 
D
OTHER 
 
DECLINE TO DISCLOSE 
 
2020-11-05 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-11-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
JOSEPH GUNNAR + CO., LLC
HAYWOOD SECURITIES (USA) INC.
HAYWOOD SECURITIES INC.
NONE